CY1107514T1 - Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια - Google Patents

Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια

Info

Publication number
CY1107514T1
CY1107514T1 CY20061101709T CY061101709T CY1107514T1 CY 1107514 T1 CY1107514 T1 CY 1107514T1 CY 20061101709 T CY20061101709 T CY 20061101709T CY 061101709 T CY061101709 T CY 061101709T CY 1107514 T1 CY1107514 T1 CY 1107514T1
Authority
CY
Cyprus
Prior art keywords
extraction
soybean
modification
hyphonda
enzymical
Prior art date
Application number
CY20061101709T
Other languages
Greek (el)
English (en)
Inventor
Marcello Duranti
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of CY1107514T1 publication Critical patent/CY1107514T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/14—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06—Ethanol, i.e. non-beverage
    • C—CHEMISTRY; METALLURGY
    • C13—SUGAR INDUSTRY
    • C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00—Glucose; Glucose-containing syrups
    • C13K1/06—Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CY20061101709T 2002-01-29 2006-11-28 Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια CY1107514T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000147A ITMI20020147A1 (it) 2002-01-29 2002-01-29 Estrazione purificazione e modificazione di polipeptidi da seme di soia
EP03706387A EP1469741B1 (en) 2002-01-29 2003-01-27 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent

Publications (1)

Publication Number Publication Date
CY1107514T1 true CY1107514T1 (el) 2013-03-13

Family

ID=11449014

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101709T CY1107514T1 (el) 2002-01-29 2006-11-28 Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια

Country Status (20)

Country Link
US (3) US7465467B2 (cg-RX-API-DMAC7.html)
EP (1) EP1469741B1 (cg-RX-API-DMAC7.html)
JP (1) JP4522706B2 (cg-RX-API-DMAC7.html)
KR (1) KR100991641B1 (cg-RX-API-DMAC7.html)
CN (1) CN100558243C (cg-RX-API-DMAC7.html)
AT (1) ATE341943T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003208346B8 (cg-RX-API-DMAC7.html)
CA (1) CA2474106C (cg-RX-API-DMAC7.html)
CY (1) CY1107514T1 (cg-RX-API-DMAC7.html)
DE (1) DE60308994T2 (cg-RX-API-DMAC7.html)
DK (1) DK1469741T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274208T3 (cg-RX-API-DMAC7.html)
IL (1) IL163225A (cg-RX-API-DMAC7.html)
IT (1) ITMI20020147A1 (cg-RX-API-DMAC7.html)
NO (1) NO327156B1 (cg-RX-API-DMAC7.html)
PL (1) PL209342B1 (cg-RX-API-DMAC7.html)
PT (1) PT1469741E (cg-RX-API-DMAC7.html)
RU (1) RU2300898C2 (cg-RX-API-DMAC7.html)
SG (1) SG152048A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003063608A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
AU2003275628B2 (en) * 2002-11-12 2008-04-03 Fuji Oil Company, Limited Fractionated soybean protein and process for producing the same
WO2005055735A1 (ja) * 2003-12-11 2005-06-23 Fuji Oil Company, Limited 改良大豆7sたん白及びその製造法
JP5382840B2 (ja) * 2005-08-23 2014-01-08 特定非営利活動法人プライメイト・アゴラ サルモデルで薬効が確認された骨粗鬆症の予防又は治療剤
BRPI0918680A2 (pt) * 2008-12-31 2015-08-25 Solae Llc "composição de proteína de soja hidrolisada, fração da proteína, produto alimentício, processo para a fabricação de uma fração de proteína, processo para a produção de um produto de proteína e produto alimentício"
EP2264054A1 (en) * 2009-06-17 2010-12-22 Indena S.p.A. Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin alfa ' subunit involved in Hep G2 cell cholesterol homeostasis
PL2264055T3 (pl) * 2009-06-17 2014-09-30 Indena Spa Klonowanie, ekspresja w drożdżach i aktywność biologiczna regionu wydłużenia podjednostki alfa globuliny sojowej 7S zaangażowanej w homeostazę cholesterolu w komórkach HepG2
CN101904406B (zh) * 2010-07-02 2012-07-25 山西大学 一种葵花籽多肽的制备方法和用途
CN104163767B (zh) * 2014-07-25 2017-01-18 湖北泓肽生物科技有限公司 一种氨基酸和多肽水溶性物质的纯化方法
CN114874301A (zh) * 2022-05-10 2022-08-09 吉林农业大学 不同亚基组成β-伴大豆球蛋白的制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409248A (en) 1981-08-10 1983-10-11 A. E. Staley Manufacturing Company Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates
JPH06197788A (ja) * 1993-01-06 1994-07-19 Fuji Oil Co Ltd 蛋白質の製造法
ES2139420T3 (es) 1996-03-28 2000-02-01 Fuji Oil Co Ltd Un procedimiento para producir un hidrolizado de proteina de soja.
JP3928811B2 (ja) * 1996-06-14 2007-06-13 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 特定のクラスのダイズ種子タンパク質遺伝子の抑制
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US6365802B2 (en) * 1998-08-14 2002-04-02 Calgene Llc Methods for increasing stearate content in soybean oil
FR2784029B1 (fr) * 1998-10-05 2001-01-05 Pharmascience Lab Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
PT1190068E (pt) * 1999-04-15 2006-06-30 Calgene Llc Sequencias de acidos nucleicos para proteinas envolvidas na sintese de tocoferol
CA2274414A1 (en) * 1999-06-11 2000-12-11 Universite Laval Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
AUPQ877300A0 (en) 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
BRPI0309421B8 (pt) * 2002-04-18 2021-05-25 Monsanto Technology Llc método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
CA2477922C (en) * 2003-08-20 2010-10-26 Seikagaku Corporation Stabilizing agent for enzymes
MX2007008496A (es) * 2005-01-14 2007-09-14 Solae Llc Proteina de soya para formula infantil.

Also Published As

Publication number Publication date
ATE341943T1 (de) 2006-11-15
CA2474106A1 (en) 2003-08-07
KR20040077786A (ko) 2004-09-06
SG152048A1 (en) 2009-05-29
ITMI20020147A0 (it) 2002-01-29
RU2300898C2 (ru) 2007-06-20
US7901718B2 (en) 2011-03-08
US8257758B2 (en) 2012-09-04
ES2274208T3 (es) 2007-05-16
PL209342B1 (pl) 2011-08-31
CN100558243C (zh) 2009-11-11
IL163225A (en) 2007-06-17
DK1469741T3 (da) 2007-02-19
KR100991641B1 (ko) 2010-11-04
US20080261885A1 (en) 2008-10-23
CN1622760A (zh) 2005-06-01
ITMI20020147A1 (it) 2003-07-29
NO20043186L (no) 2004-07-26
PL370294A1 (en) 2005-05-16
AU2003208346A2 (en) 2003-09-02
US20050164337A1 (en) 2005-07-28
AU2003208346B2 (en) 2008-03-06
JP4522706B2 (ja) 2010-08-11
EP1469741B1 (en) 2006-10-11
DE60308994T2 (de) 2007-06-14
US7465467B2 (en) 2008-12-16
AU2003208346B8 (en) 2008-07-10
RU2004123201A (ru) 2005-10-27
EP1469741A1 (en) 2004-10-27
PT1469741E (pt) 2007-01-31
NO327156B1 (no) 2009-05-04
CA2474106C (en) 2011-11-22
JP2005516043A (ja) 2005-06-02
DE60308994D1 (de) 2006-11-23
WO2003063608A1 (en) 2003-08-07
HK1073590A1 (zh) 2005-10-14
US20110118182A1 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
US8501439B2 (en) Method for obtaining active pro-NGF and beta-NGF
CY1108424T1 (el) Μεθοδοι για τη βελτιωση της διαμορφωσης πρωτεϊνων με τη βοηθεια αναγωγικων μεσων
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
DE60027406D1 (de) Rückgewinnung eines proteins bei hohem ph-wert
EA200201214A1 (ru) Замещенные тиоацетамиды
BG103694A (bg) Метод за получаване и пречистване на n- алкилирано аспарагиново производно
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
WO2002080858A3 (en) Use of kpv tripeptide for dermatological disorders
YU50502A (sh) Postupak za prečišćavanje farmakološki aktivnih proteina pomoću katjonske izmenjivačke hromatografije
BR9809914A (pt) Genes de moracella receptores de lactoferrina
ATE322503T1 (de) Gefrierschutzprotein
DE69935078D1 (de) Eine mutante phospholamban moleküle und deren verwendung zur behandlung von herzkrankheiten und herzversagen
DE60335726D1 (de) Chromoprotein und fluoroproteine
NO20015247L (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
NO993151L (no) Fremgangsmåte for fremstilling av renset dimer av benavledet faktor
ATE341943T1 (de) Verfahren zur extraktion, reinigung und enzymatischen veränderung von soja 7s globulin alpha' untereinheit zur verwendung als hypocholesterol-mischer-wirkstoff
CA1332998C (en) Prostate-derived growth factor
DK0794255T3 (da) Fremgangsmåde til spaltning af kimært protein ved anvendelse af processeringsenzym
JP2005516043A5 (cg-RX-API-DMAC7.html)
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
Mirfakhrai et al. Chemical Cleveland mapping: a rapid technique for characterization of crosslinked nucleic acid-protein complexes
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
Minkiewicz-Radziejewska et al. Disulfide-bound proteolytic fragments of gastric mucin are 100-and 140-kDa proteins
WO2003036264A3 (en) Treating diseases mediated by metalloprotease-shed proteins
DE60005526D1 (de) Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes